Commercial APIs
S.No: | Product | Therapeutic Category | Grades | Regulatory documents |
---|---|---|---|---|
1 | Terbinafine HCl | Anti-Fungal | IP/USP/EP/JP/BP | DMF; (CEP Filed) |
2 | Camphor | Anti-Infective | IP/USP/EP/JP/BP | O-DMF |
3 | Ezetimibe | Antihyperlipidemic | IP/USP | DMF |
4 | Solifenacin Succinate | Urinary Antispasmodic | IH/USP/EP/BP | O-DMF |
5 | Prasugrel HCl | Anti-Platlet | IH/USP/EP/BP | O-DMF |
6 | Apremilast | Psoriatic arthritis | IH | Under development ( Feb 2021) |
7 | Ticagrelor | Anti-Platelet | IH | Under development ( Jan 2021) |
8 | Apixaban | Anti-coagulant | IH | Under development ( March 2021) |
9 | Rivaroxaban | Anti-coagulant | IH | Under development ( May 2021) |
10 | Edoxaban | Anti-coagulant | IH | Under development ( March 2021) |